Skip to content
AIHCM - American Institute of Healthcare Management
All programs
GLP1Professional·Medication & Pharmacy Practice

Obesity Care and GLP-1 Medicines: A Practical Update

What changed when GLP-1 medicines entered routine obesity care.

Obesity Care and GLP-1 Medicines: A Practical Update

Program overview

The first global guideline on GLP-1 medicines for obesity was issued in December 2025, and explicitly cited health-system unpreparedness as a limitation. This course addresses that gap. It covers obesity as a chronic disease rather than a lifestyle failure, assessment and comorbidity screening, where GLP-1 receptor agonists fit alongside nutrition and behavioural support, dosing escalation and adverse effect management, monitoring, the questions patients actually ask, and the equity and supply issues. Particularly relevant in regions with high metabolic disease prevalence.

Why this program

Reflects the 2025 global guideline

Obesity framed as a chronic disease

Adverse effect management taught practically

Addresses the questions patients actually ask

Who it is for

PhysicianNursePharmacistNutritionistAllied Health

Program objectives

  • Describe obesity as a chronic relapsing disease with metabolic drivers
  • Assess a patient for obesity-related comorbidity
  • Explain where GLP-1 receptor agonists fit within a care pathway
  • Apply dose escalation and manage common adverse effects
  • Monitor treatment response and recognise when to reassess
  • Respond to common patient questions and expectations

Learning outcomes

  • Assess a described patient for obesity-related comorbidity
  • Identify appropriate candidates for GLP-1 therapy from clinical criteria
  • Apply a dose escalation approach to a described case
  • Manage a described adverse effect appropriately
  • Evaluate treatment response against expected trajectory
  • Recommend nutritional and behavioural support alongside pharmacotherapy

Curriculum

Module 1: Obesity as Chronic Disease

1 lessons
  • Obesity as Chronic DiseasePreview

    Physiology, weight regulation and why willpower framing fails.

Module 2: Assessment and Comorbidity

1 lessons
  • Assessment and Comorbidity

Module 3: Where GLP-1 Medicines Fit

1 lessons
  • Where GLP-1 Medicines Fit

Module 4: Dosing and Adverse Effects

1 lessons
  • Dosing and Adverse Effects

Module 5: Monitoring, Nutrition and Expectations

1 lessons
  • Monitoring, Nutrition and Expectations

Duration and structure

3h
Total study hours
2.5h
Content
0.5h
Assessment

5 lessons across 5 modules. Duration is expressed in study hours.

What you receive

Verifiable AIHCM digital certificate

This certificate confirms completion of Obesity Care and GLP-1 Medicines: A Practical Update. Duration is expressed in study hours.

Delivery format

  • Self-paced — start any time.
  • Study on any device.
  • Lifetime access to the version you enrolled in.

Program handbook

Open the program handbook (print / save as PDF)